Crowd Trend Signals | 2026-05-05 | Quality Score: 96/100
Free US stock put/call ratio analysis and sentiment contrarian indicators for market timing signals and sentiment assessment. We monitor options market activity to understand when markets might be too bullish or bearish and due for a reversal. We provide put/call ratio analysis, sentiment contrarian signals, and market timing indicators for comprehensive coverage. Time the market with our comprehensive sentiment analysis and contrarian indicators tools for contrarian investing.
This analysis evaluates Tempus AI (NASDAQ: TEM), a high-growth AI-powered diagnostics and healthcare data firm that previously benefited from widely followed trade disclosures by former U.S. House Speaker Nancy Pelosi, ahead of its Q1 2026 after-hours earnings release on May 5, 2026. We benchmark TE
Live News
As of market close on May 4, 2026, institutional and retail investors are actively positioning in Tempus AI ahead of its first-quarter 2026 financial results, scheduled for publication after the closing bell on May 5. The stock first entered mainstream investment portfolios in January 2025, following public regulatory disclosure that Nancy Pelosi had initiated a material long position, sparking a sentiment-driven rally that pushed shares above $100 per share. Since that 2025 peak, TEM has correc
Invesco QQQ Trust (QQQ) - Tempus AI (TEM) Catalyst Preview Ahead of Q1 2026 Earnings ReleaseThe use of predictive models has become common in trading strategies. While they are not foolproof, combining statistical forecasts with real-time data often improves decision-making accuracy.Many investors underestimate the importance of monitoring multiple timeframes simultaneously. Short-term price movements can often conflict with longer-term trends, and understanding the interplay between them is critical for making informed decisions. Combining real-time updates with historical analysis allows traders to identify potential turning points before they become obvious to the broader market.Invesco QQQ Trust (QQQ) - Tempus AI (TEM) Catalyst Preview Ahead of Q1 2026 Earnings ReleaseGlobal interconnections necessitate awareness of international events and policy shifts. Developments in one region can propagate through multiple asset classes globally. Recognizing these linkages allows for proactive adjustments and the identification of cross-market opportunities.
Key Highlights
First, prior fundamental momentum supports long-term growth expectations: TEM posted 83% year-over-year revenue growth in Q4 2025 to $367.21 million, driven by a 121.6% jump in its Diagnostics segment, and recorded its first positive adjusted EBITDA of $12.89 million, following a slim $1.48 million adjusted EBITDA print in Q3 2025. Management previously guided for full-year 2026 adjusted EBITDA of $65 million, alongside 40% year-over-year growth in its Insights data segment for Q1 2026, 126% net
Invesco QQQ Trust (QQQ) - Tempus AI (TEM) Catalyst Preview Ahead of Q1 2026 Earnings ReleaseReal-time data is especially valuable during periods of heightened volatility. Rapid access to updates enables traders to respond to sudden price movements and avoid being caught off guard. Timely information can make the difference between capturing a profitable opportunity and missing it entirely.Observing how global markets interact can provide valuable insights into local trends. Movements in one region often influence sentiment and liquidity in others.Invesco QQQ Trust (QQQ) - Tempus AI (TEM) Catalyst Preview Ahead of Q1 2026 Earnings ReleaseReal-time tracking of futures markets often serves as an early indicator for equities. Futures prices typically adjust rapidly to news, providing traders with clues about potential moves in the underlying stocks or indices.
Expert Insights
While TEM’s 2025 rally was largely driven by retail and institutional enthusiasm tied to Pelosi’s long track record of market-beating trades, the stock now trades entirely on fundamental execution, with three non-negotiable catalysts required to restart upward momentum and narrow its performance gap to the QQQ’s large-cap AI and tech holdings. First, sustained adjusted EBITDA profitability: Q4 2025 marked the first quarter of positive adjusted EBITDA for the firm, and a second consecutive positive print will validate management’s cost optimization and revenue scaling efforts, putting the $65 million full-year EBITDA target within reach. A return to negative EBITDA, by contrast, will invalidate the company’s path to near-term profitability, likely triggering a 15% to 20% selloff based on historical implied volatility, and widen its performance gap to the profitable, cash-flow generative constituents of the QQQ. Second, Insights segment execution: Management’s 40% Q1 growth guidance for the data business, paired with 126% net revenue retention, will need to be supported by broad-based pharma client onboarding, rather than one-time contract wins or warrant revenue, to prove the segment’s recurring revenue moat. Third, MRD volume acceleration: The MRD testing line is TEM’s largest long-term growth lever, with current market penetration at less than 2% of the estimated $20 billion global addressable market. Even a 20% sequential increase in MRD volumes, paired with evidence of expanded sales force allocation to the product, will signal that the company’s next leg of growth is already underway, supporting a re-rating of the stock to a 12x forward revenue multiple, in line with high-growth profitable AI diagnostics peers, from its current 7x multiple. It is important to note that isolated earnings beats will not be sufficient to drive sustainable gains, as seen after the Q3 2025 37.25% EPS beat that still resulted in a negative share price reaction. For TEM to outperform the QQQ over the next 12 months, management will need to deliver on all three core metrics, and provide upward revisions to full-year 2026 revenue and EBITDA guidance. Failure to hit any of the three key targets will extend the stock’s consolidation phase, and make a return to its 2025 $100 per share peak unlikely over the next 18 months. (Word count: 1128)
Invesco QQQ Trust (QQQ) - Tempus AI (TEM) Catalyst Preview Ahead of Q1 2026 Earnings ReleaseWhile data access has improved, interpretation remains crucial. Traders may observe similar metrics but draw different conclusions depending on their strategy, risk tolerance, and market experience. Developing analytical skills is as important as having access to data.Real-time news monitoring complements numerical analysis. Sudden regulatory announcements, earnings surprises, or geopolitical developments can trigger rapid market movements. Staying informed allows for timely interventions and adjustment of portfolio positions.Invesco QQQ Trust (QQQ) - Tempus AI (TEM) Catalyst Preview Ahead of Q1 2026 Earnings ReleaseDiversification in analysis methods can reduce the risk of error. Using multiple perspectives improves reliability.
